FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

Flow diagram illustrating the sequence of procedures executed during one time step defined as tick, each of which represents one week. by Alexandra M. Campbell (3284094)

Subjects:

ABM NetLogo File. by Alexandra M. Campbell (3284094)

Subjects:

Flow diagram representing bromeliad death by overcrowding within the Bromeliad-death procedure. by Alexandra M. Campbell (3284094)

Subjects:

Estimated parameters for distribution of basal area. by Alexandra M. Campbell (3284094)

Subjects:

Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

MRSP Tree Host Data. by Alexandra M. Campbell (3284094)

Subjects:

<i>Tillandsia utriculata</i> death rate data by size class. by Alexandra M. Campbell (3284094)

Subjects:

Histograms of (A) distance measured in meters to nearest neighboring tree given bin widths of 2 m (<i>n</i> = 44), and (B) basal areas of all sampled trees (<i>n</i> = 58; bin widt... by Alexandra M. Campbell (3284094)

Subjects:

Parameter sets generated through Latin hypercube sampling. by Alexandra M. Campbell (3284094)

Subjects:

Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Subjects:

Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Starvation improves locomotory capacity and decreases the number of α-synuclein-YFP aggregates of transgenic <i>C. elegans</i> through LMP-1 dependent mechanism. by María Gallardo-Campos (22170919)

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

SIM and SIMA detection in real samples. by Ewa Paszkowska (21246702)

Subjects:

Changes in health-related quality of life indexes before and after disease onset. by Ji Woong Chang (1829314)

Subjects:

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

Subjects:

The characteristics of patient groups were used to prove the method’s applicability. by Ewa Paszkowska (21246702)

Subjects:

The observed MRM reactions. by Ewa Paszkowska (21246702)

Subjects:

Differences in health-related quality of life indexes after disease onset between groups. by Ji Woong Chang (1829314)

Subjects: